|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008059,
umls-concept:C0011209,
umls-concept:C0013216,
umls-concept:C0035647,
umls-concept:C0205197,
umls-concept:C0238598,
umls-concept:C0750974,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2349975,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-6-2
|
|
pubmed:abstractText |
Radiographic tumor response and survival were evaluated in the pediatric and young adult population with germ cell tumor, primary CNS lymphoma, or primitive neuroectodermal tumor receiving intra-arterial carboplatin- or methotrexate-based chemotherapy with osmotic blood-brain barrier disruption (BBBD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1081-4442
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
110-24
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9532413-Adolescent,
pubmed-meshheading:9532413-Adult,
pubmed-meshheading:9532413-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9532413-Blood-Brain Barrier,
pubmed-meshheading:9532413-Brain Neoplasms,
pubmed-meshheading:9532413-Carboplatin,
pubmed-meshheading:9532413-Child,
pubmed-meshheading:9532413-Child, Preschool,
pubmed-meshheading:9532413-Cyclophosphamide,
pubmed-meshheading:9532413-Diuretics, Osmotic,
pubmed-meshheading:9532413-Etoposide,
pubmed-meshheading:9532413-Female,
pubmed-meshheading:9532413-Follow-Up Studies,
pubmed-meshheading:9532413-Germinoma,
pubmed-meshheading:9532413-Humans,
pubmed-meshheading:9532413-Infant,
pubmed-meshheading:9532413-Injections, Intra-Arterial,
pubmed-meshheading:9532413-Lymphoma,
pubmed-meshheading:9532413-Male,
pubmed-meshheading:9532413-Mannitol,
pubmed-meshheading:9532413-Methotrexate,
pubmed-meshheading:9532413-Neuroectodermal Tumors, Primitive,
pubmed-meshheading:9532413-Neuropsychological Tests,
pubmed-meshheading:9532413-Survival Rate,
pubmed-meshheading:9532413-Treatment Outcome
|
|
pubmed:articleTitle |
The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
|
|
pubmed:affiliation |
Department of Neurology, Oregon Health Sciences University, Portland 97201-3098, USA.
|
|
pubmed:publicationType |
Journal Article
|
